Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes;Stenie wisfatyny w surowicy kobiet cíarnych z zaburzeniami tolerancji glukozy

Ginekologia Polska

Volumn 80, Issue 1, 2009, Pages 14-18

  Szamatowicz, Jacek ^a   Kuêmicki, Mariusz ^a   Telejko, Beata ^a   Zonenberg, Anna ^a   Nikołajuk, Agnieszka ^a   Kŕetowski, Adam ^a   Górska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Gestational diabetes mellitus; Pregnancy; Visfatin

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; PREGNANCY; PREGNANCY DIABETES MELLITUS; REFERENCE VALUE; WOMEN'S HEALTH;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PREGNANCY; REFERENCE VALUES; WOMEN'S HEALTH;

EID: 64549130484     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Samal B, Sun Y, Stearns G, [et al.]. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994, 14, 1431-1437.
2. Berndt J, Klöting N, Kralisch S, [et al.]. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes. 2005, 54, 2911-2916.
3. Varma V, Yao-Borengasser A, Rasouli N, [et al.]. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab. 2007, 92, 666-672.
4. Curat C, Wegner V, Sengenes C, [et al.]. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006, 49, 744-747.
5. Ognjanovic S, Bao S, Yamamoto S, [et al.]. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol. 2001, 26, 107-117.
6. Ognjanovic S, Bryant-Greenwood G. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes Am J Obstet Gynecol. 2002, 187, 1051-1058.
7. Rongvaux A, Shea R, Mulks M, [et al.]. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyl- transferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002, 32, 3225-3234.
8. Revollo J, Korner A, Mills K, [et al.]. Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007, 6, 363-375.
9. Haider D, Pleiner J, Francesconi M, [et al.]. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab. 2006, 91, 4702- 4704.
10. López-Bermejo A, Chico-Julia B, Fern_ndez-Balsells M, [et al.]. Serum visfatin increases with progressive beta-cell deterioration. Diabetes. 2006, 55, 2871-2875.
11. Chen M, Chung F, Chang D, [et al.]. Elevated plasma level of visfatin/pre-B cell colony- enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2006, 91, 295-299.
12. Dogru T, Sonmez A, Tasci I, [et al.]. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract. 2007, 76, 24-29.
13. Fernández-Real J, Moreno J, Chico B, [et al.]. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care. 2007, 30, 616-621.
14. Hammarstedt A, Pihlajamäki J, Rotter Sopasakis V, [et al.]. Visfatin is an adipokine, but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab. 2006, 91, 1181-1184.
15. Li L, Yang G, Li Q, [et al.]. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 2006, 114, 544-548.
16. Haider D, Schindler K, Schaller G, [et al.]. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006, 91, 1578-1581.
17. Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, [et al.]. Serum concentration of visfatin in obese women. Metabolism. 2007, 56, 1131-1134.
18. Pagano C, Pilon C, Olivieri M, [et al.]. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab. 2006, 91, 3165-3170.
19. Fasshauer M, Blüher M, Stumvoll M, [et al.]. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf). 2007, 66, 434-443.
20. Fasshauer M, Waldeyer T, Seeger J, [et al.]. Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf). 2008, 69, 69-73.
21. Chan T, Chen Y, Lee C, [et al.] Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Invest. 2006, 13, 364-367.
22. Haider D, Handisurya A, Storka A, [et al.]. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care. 2007, 30, 1889-1891.
23. Krzyzanowska K, Krugluger W, Mittermayer F, [et al.]. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Science (Lond). 2006, 110, 605-609.
24. Lewandowski K, Stojanovic N, Press M, [et al.] Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degree of glucose tolerance. Diabetologia. 2007, 50, 1033-1037.
25. Alberti K, Zimmet P. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15, 539- 553.
26. Carpenter M. Metabolic changes in gestational diabetes. Clin Perinatol. 1993, 20, 583- 591.
27. Mastorakos G, Valsamakis G, Papatheodorou D, [et al.]. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem. 2007, 53, 1477-1483.
28. Haider D, Schaller G, Kapiotis S, [et al.]. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia. 2006, 49, 1909-1914.